CYROMAZINE MARKET ANALYSIS

Cyromazine is an insect growth regulator (IGR) and is a cyclopropyl & an aminotriazine derivative of melamine. Cyromazine finds application in animal healthcare and agriculture. Cyromazine and other IGRs interfere with the life cycle of insects by acting on the hormonal control of development. IGRs interfere with normal progress and growth of the insect, resulting in an insect’s mortality before it reaches adulthood.

Global cyromazine market was valued at US$ 1.4 Million in 2021 in terms of revenue, exhibiting a CAGR of XX% during the forecast period (2022 to 2030).

Drivers

Cyromazine is an insect growth regulator (IGR) or ectoparasiticide that disrupts the development of insects and is effective against leaf miners and fly larvae. Increasing population and rising disposable income of the population is resulting in huge demand for food items and agriculture products, which in turn increases the demand for IGRs.

Among region, Asia Pacific is the fastest growing region and accounted for the largest market share of 37.2% in 2021, owing to growing agricultural industry in economies such as India in this region. According to India Brand Equity Foundation report on Agriculture and Allied Industries published in May 2018, food grain production was 279.51 million tons in India during crop year of 2017-2018. The report also states that there is a rising demand for Indian food and agricultural products in the international market. The total agricultural exports from India witnessed a CAGR of 16.45% over FY10-18 to reach US$ 38.21 billion in FY18. In April 2018, agriculture exports was US$ 3.15 billion. Therefore, growth of agricultural industry is expected to increase crop protection solutions, which in turn is expected to propel demand for cyromazine insecticides.

Figure 1. Global Cyromazine Market Value Share (%), By Region, 2021

To learn more about this report, request sample copy

Market Restraints

The slow-acting impact of cyromazine and availability of substitutes to cyromazine such as methoprene are expected to restrain the market growth. Furthermore, the development of resistance towards insect growth regulators is expected to be one of the major challenges restraining the market growth.

Market Trends

Increasing demand for environmentally safe crop protection products is expected to drive growth of the cyromazine market, owing to benefits offered by cyromazine such as low toxicity and lesser harmful impact on the environment. According to the USDA report on agricultural statistics published in 2017, domestic utilization of grains increased from 349.8 million metric tons in 2015 to 368 million metric tons in 2016 in the U.S. Therefore, growing agricultural sector is expected to result in increasing crop protection requirements, which in turn is expected to drive demand for cyromazine.

Figure 2. Global Cyromazine Market Value Share (%), By Application, 2021

To learn more about this report, request sample copy

Among applications, crop protection segment accounted for the largest revenue share of 78.4% in the global cyromazine market in 2021. There is high demand for insect growth regulators such as cyromazine in the agriculture industry to protect crops from insects and thereby improve agriculture production.

Recent Developments

• In 2021, RR Animal Health Care Ltd. developed Cyromazine Active Pharmaceutical Ingredient (API) for the poultry segment. With the development of Cyromazine 99.5%, RR Animal Health Care became the first company to develop this molecule with complete backward integration using a Green Chemistry route without the use of solvents.
• In July 2019, MGK, a provider of insect control solutions, acquired the Flynexx brand assets from North Carolina-based Piedmont Animal Health. The acquisition includes the Flynexx Granules fly control product and an Environmental Protection Agency EPA registration for IGR cyromazine.
• In September 2019, Shandong Luxi Animal Medicine Share Co., Ltd. launched its animal nutrition product Cyromazine at the Qingdao World Expo City located in china.

Competitive Section

Major players operating in the global cyromazine market include Syngenta AG, ADAMA Agricultural Solutions Ltd., Elanco Animal Health Inc., Jurox Pty Limited., Arysta LifeScience Corporation, Lasa Supergenerics Limited, Orion AgriScience Limited, Topsen Biotech Co. Ltd., Shandong Luxi Animal Medicine Share Co., Ltd., Bayer AG, and Toronto Research Chemicals Inc.